These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19557937)

  • 1. Echinocandins: pharmacokinetic and therapeutic issues.
    Cleary JD
    Curr Med Res Opin; 2009 Jul; 25(7):1741-50. PubMed ID: 19557937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of invasive candidiasis with echinocandins.
    Glöckner A; Steinbach A; Vehreschild JJ; Cornely OA
    Mycoses; 2009 Nov; 52(6):476-86. PubMed ID: 19076282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Echinocandins in invasive candidiasis].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micafungin for the prophylaxis and treatment of Candida infections.
    Fritz JM; Brielmaier BD; Dubberke ER
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):153-62. PubMed ID: 18380597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of candidemia and invasive candidiasis according to guidelines].
    Glöckner A
    Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micafungin: a new echinocandin antifungal.
    Joseph JM; Jain R; Danziger LH
    Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.
    Garnacho-Montero J; Díaz-Martín A; Cayuela-Dominguez A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S137-41. PubMed ID: 19013338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anidulafungin in the treatment of patients with invasive candidiasis.
    Kett DH; Cubillos GF
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S99-S102. PubMed ID: 19013348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and antifungal properties of anidulafungin, a new echinocandin.
    Estes KE; Penzak SR; Calis KA; Walsh TJ
    Pharmacotherapy; 2009 Jan; 29(1):17-30. PubMed ID: 19113794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical review of echinocandins in pediatric patients.
    VandenBussche HL; Van Loo DA
    Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.
    Wagner C; Graninger W; Presterl E; Joukhadar C
    Pharmacology; 2006; 78(4):161-77. PubMed ID: 17047411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacodynamics and pharmacokinetics on echinocandin dosing strategies.
    Gumbo T
    Curr Opin Infect Dis; 2007 Dec; 20(6):587-91. PubMed ID: 17975408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE
    Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.